1. Boehringer Ingelheim

Boehringer Ingelheim Mexico offices
Boehringer Ingelheim leads the pharma industry as the top performer in ESG issues to kick off 2021. (Boehringer Ingelheim)

Boehringer Ingelheim
Rating: +49
Notable ESG scores:
Employee Engagement, Diversity & Inclusion (+29)
Human Rights & Community Relations (+11)
Product Quality & Safety (+4)

Boehringer Ingelheim ranked highest among pharma companies for ESG in early 2021 with an Alva score of +49 on a scale that runs from -100 to +100.

It earned high marks in diversity and inclusion and also human rights and community relations, but maybe more importantly in the pharma category, it had no significant negative coverage.

One measurement Alva noted was Boehringer’s ranking as one of the 16 best employers in the world by independent group Top Employers Institute; the company picked up top honors in 27 countries. The annual ranking lauded Boehringer for its strong, inclusive corporate culture.

RELATED: BI, Gilead execs highlight value of disease awareness campaigns—particularly during the pandemic

“Compared to its competitors, the company particularly impressed with its successful long-term strategic orientation, as well as with a modern management culture and successful communication with employees,” the evaluator noted.

Another plus in Alva’s assessment is BI’s hiring of a new U.S. president for animal health who is focused on “enhancing the well-being of people and animals”.

BI also earned kudos from Alva in environmental measures, pointing to its switch to wind energy at a St. Joseph, Missouri, manufacturing site where it makes vaccines for animals. Alva researchers said the move aligns with BI’s “companywide, global commitment towards environmental sustainability.”

RELATED: Boehringer Ingelheim lines up celebrity judges for songwriting contest in lung disease awareness campaign

The pharma company scored the first-quarter top finish, moving up from No. 4 in Alva’s previous ranking.

1. Boehringer Ingelheim